These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1433 related items for PubMed ID: 17174178

  • 21. Comparison of sirolimus-eluting stents with paclitaxel-eluting stents in saphenous vein graft intervention (from a multicenter Southern California Registry).
    Lee MS, Hu PP, Aragon J, Shah AP, Oyama J, Dhoot J, Iqbal Z, Jones N, Penny W, Tobis J, Mahmud E, French W.
    Am J Cardiol; 2010 Aug 01; 106(3):337-41. PubMed ID: 20643242
    [Abstract] [Full Text] [Related]

  • 22. Clinical and angiographic outcome after sirolimus-eluting stent implantation in aorto-ostial lesions.
    Iakovou I, Ge L, Michev I, Sangiorgi GM, Montorfano M, Airoldi F, Chieffo A, Stankovic G, Vitrella G, Carlino M, Corvaja N, Briguori C, Colombo A.
    J Am Coll Cardiol; 2004 Sep 01; 44(5):967-71. PubMed ID: 15337205
    [Abstract] [Full Text] [Related]

  • 23. Randomized evaluation of polytetrafluoroethylene-covered stent in saphenous vein grafts: the Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) Trial.
    Stankovic G, Colombo A, Presbitero P, van den Branden F, Inglese L, Cernigliaro C, Niccoli L, Bartorelli AL, Rubartelli P, Reifart N, Heyndrickx GR, Saunamäki K, Morice MC, Sgura FA, Di Mario C, Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts investigators.
    Circulation; 2003 Jul 08; 108(1):37-42. PubMed ID: 12821546
    [Abstract] [Full Text] [Related]

  • 24. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
    Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, Williams J, Farhat N, Caputo R, Xenopoulos N, Applegate R, Gordon P, White RM, Sudhir K, Cutlip DE, Petersen JL, SPIRIT III Investigators.
    Circulation; 2009 Feb 10; 119(5):680-6. PubMed ID: 19171853
    [Abstract] [Full Text] [Related]

  • 25. Three-year clinical outcome after primary stenting of totally occluded native coronary arteries: a randomized comparison of bare-metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (Primary Stenting of Totally Occluded Native Coronary Arteries [PRISON] II study).
    Rahel BM, Laarman GJ, Kelder JC, Ten Berg JM, Suttorp MJ.
    Am Heart J; 2009 Jan 10; 157(1):149-55. PubMed ID: 19081412
    [Abstract] [Full Text] [Related]

  • 26. Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trial.
    Jiménez-Quevedo P, Sabaté M, Angiolillo DJ, Alfonso F, Hernández-Antolín R, SanMartín M, Gómez-Hospital JA, Bañuelos C, Escaned J, Moreno R, Fernández C, Fernández-Avilés F, Macaya C, DIABETES Investigators.
    Eur Heart J; 2007 Aug 10; 28(16):1946-52. PubMed ID: 17562666
    [Abstract] [Full Text] [Related]

  • 27. Comparison of sirolimus versus paclitaxel eluting stents for treatment of coronary in-stent restenosis.
    Airoldi F, Briguori C, Iakovou I, Stankovic G, Biondi-Zoccai G, Carlino M, Chieffo A, Montorfano M, Cosgrave J, Michev I, Rogacka R, Sangiorgi GM, Colombo A.
    Am J Cardiol; 2006 Apr 15; 97(8):1182-7. PubMed ID: 16616023
    [Abstract] [Full Text] [Related]

  • 28. Immediate and mid-term outcomes of sirolimus-eluting stent implantation for chronic total occlusions.
    Ge L, Iakovou I, Cosgrave J, Chieffo A, Montorfano M, Michev I, Airoldi F, Carlino M, Melzi G, Sangiorgi GM, Corvaja N, Colombo A.
    Eur Heart J; 2005 Jun 15; 26(11):1056-62. PubMed ID: 15817605
    [Abstract] [Full Text] [Related]

  • 29. Clinical outcomes after sirolimus-eluting stent implantation for de novo saphenous vein graft lesions.
    Price MJ, Sawhney N, Kao JA, Madrid A, Schatz RA, Teirstein PS.
    Catheter Cardiovasc Interv; 2005 Jun 15; 65(2):208-11. PubMed ID: 15880798
    [Abstract] [Full Text] [Related]

  • 30. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.
    Mehilli J, Kastrati A, Byrne RA, Bruskina O, Iijima R, Schulz S, Pache J, Seyfarth M, Massberg S, Laugwitz KL, Dirschinger J, Schömig A, LEFT-MAIN Intracoronary Stenting and Angiographic Results: Drug-Eluting Stents for Unprotected Coronary Left Main Lesions Study Investigators.
    J Am Coll Cardiol; 2009 May 12; 53(19):1760-8. PubMed ID: 19422982
    [Abstract] [Full Text] [Related]

  • 31. Long-term clinical outcomes and stent thrombosis of sirolimus-eluting versus bare metal stents in patients with end-stage renal disease: results of Korean multicenter angioplasty team (KOMATE) Registry.
    Kim BK, Oh S, Jeon DW, Yang JY, Kim JS, Park S, Choi D, Jang Y, Hong BK, Kwon HM, Lee SW, Goh CW, Kwon K, Ryu SK, Korean Multicenter Angioplasty Team (KOMATE) Investigators.
    J Interv Cardiol; 2009 Oct 12; 22(5):411-9. PubMed ID: 19702679
    [Abstract] [Full Text] [Related]

  • 32. Sirolimus-eluting versus uncoated stents in acute myocardial infarction.
    Spaulding C, Henry P, Teiger E, Beatt K, Bramucci E, Carrié D, Slama MS, Merkely B, Erglis A, Margheri M, Varenne O, Cebrian A, Stoll HP, Snead DB, Bode C, TYPHOON Investigators.
    N Engl J Med; 2006 Sep 14; 355(11):1093-104. PubMed ID: 16971716
    [Abstract] [Full Text] [Related]

  • 33. Firebird sirolimus eluting stent versus bare mental stent in patients with ST-segment elevation myocardial infarction.
    Gao H, Yan HB, Zhu XL, Li N, Ai H, Wang J, Li SY, Yang D.
    Chin Med J (Engl); 2007 May 20; 120(10):863-7. PubMed ID: 17543174
    [Abstract] [Full Text] [Related]

  • 34. Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH Registries).
    Daemen J, Tanimoto S, García-García HM, Kukreja N, van de Sande M, Sianos G, de Jaegere PP, van Domburg RT, Serruys PW.
    Am J Cardiol; 2007 Apr 15; 99(8):1027-32. PubMed ID: 17437722
    [Abstract] [Full Text] [Related]

  • 35. Impact of significant chronic kidney disease on long-term clinical outcomes after drug-eluting stent versus bare metal stent implantation.
    Jeong YH, Hong MK, Lee CW, Park DW, Kim YH, Kim JJ, Park SW, Park SJ.
    Int J Cardiol; 2008 Mar 28; 125(1):36-40. PubMed ID: 17521753
    [Abstract] [Full Text] [Related]

  • 36. Comparable clinical outcomes with paclitaxel- and sirolimus-eluting stents in unrestricted contemporary practice.
    Cosgrave J, Melzi G, Corbett S, Biondi-Zoccai GG, Agostoni P, Babic R, Airoldi F, Chieffo A, Sangiorgi GM, Montorfano M, Michev I, Carlino M, Colombo A.
    J Am Coll Cardiol; 2007 Jun 19; 49(24):2320-8. PubMed ID: 17572247
    [Abstract] [Full Text] [Related]

  • 37. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
    Whan Lee C, Kim SH, Suh J, Park DW, Lee SH, Kim YH, Hong MK, Kim JJ, Park SW, Park SJ.
    Catheter Cardiovasc Interv; 2008 Apr 01; 71(5):594-8. PubMed ID: 18311841
    [Abstract] [Full Text] [Related]

  • 38. The Stenting Coronary Arteries in Non-stress/benestent Disease (SCANDSTENT) trial.
    Kelbaek H, Thuesen L, Helqvist S, Kløvgaard L, Jørgensen E, Aljabbari S, Saunamäki K, Krusell LR, Jensen GV, Bøtker HE, Lassen JF, Andersen HR, Thayssen P, Galløe A, van Weert A, SCANDSTENT Investigators.
    J Am Coll Cardiol; 2006 Jan 17; 47(2):449-55. PubMed ID: 16412876
    [Abstract] [Full Text] [Related]

  • 39. Clinical outcomes of serolimus-eluting stents versus bare metal stents in ST-segment elevation myocardial infarction patients: a meta-analysis.
    Pan XH, Zhong WZ, Xiang MX, Xu G, Shan J, Wang JA.
    Chin Med J (Engl); 2009 Jan 05; 122(1):88-92. PubMed ID: 19187623
    [Abstract] [Full Text] [Related]

  • 40. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial.
    Sabaté M, Jiménez-Quevedo P, Angiolillo DJ, Gómez-Hospital JA, Alfonso F, Hernández-Antolín R, Goicolea J, Bañuelos C, Escaned J, Moreno R, Fernández C, Fernández-Avilés F, Macaya C, DIABETES Investigators.
    Circulation; 2005 Oct 04; 112(14):2175-83. PubMed ID: 16203930
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 72.